Immunological Cross-Reactivity and Neutralisation of European Viper Venoms with the Monospecific Vipera berus Antivenom ViperaTAb
Open Access
Abstract
Medically important cases of snakebite in Europe are predominately caused by European vipers of the genus Vipera. The mainstay of snakebite therapy is polyclonal antibody therapy, referred to as antivenom. Here we investigate the capability of the monospecific V. berus antivenom, ViperaTAb®, to cross-react with, and neutralise lethality induced by, a variety of European vipers. Using ELISA and immunoblotting, we find that ViperaTAb® antibodies recognise and bind to the majority of toxic components found in the venoms of the Vipera species tested at comparably high levels to those observed with V. berus. Using in vivo pre-clinical efficacy studies, we demonstrate that ViperaTAb® effectively neutralises lethality induced by V. berus, V. aspis, V. ammodytes and V. latastei venoms and at much higher levels than those outlined by regulatory pharmacopoeial guidelines. Notably, venom neutralisation was found to be superior to (V. berus, V. aspis and V. latastei), or as equally effective as (V. ammodytes), the monospecific V. ammodytes “Zagreb antivenom”, which has long been successfully used for treating European snake envenomings. This study suggests that ViperaTAb® may be a valuable therapeutic product for treating snakebite by a variety of European vipers found throughout the continent.Keywords
This publication has 33 references indexed in Scilit:
- Pre-Clinical Assays Predict Pan-African Echis Viper Efficacy for a Species-Specific AntivenomPLOS Neglected Tropical Diseases, 2010
- Snake Envenoming: A Disease of PovertyPLOS Neglected Tropical Diseases, 2009
- Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: An integrative reviewBMC Emergency Medicine, 2009
- Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcriptsBMC Genomics, 2009
- The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and DeathsPLOS Medicine, 2008
- Neurotoxicity and hypertension following European adder (Vipera berus berus) bites in Hungary: case report and reviewQJM: An International Journal of Medicine, 2008
- Reappraisal of Vipera aspis Venom NeurotoxicityPLOS ONE, 2007
- Treatment of bites by adders and exotic venomous snakesBMJ, 2005
- Pharmacokinetic-Pharmacodynamic Relationships of Immunoglobulin Therapy for EnvenomationClinical Pharmacokinetics, 2003
- Ammodytoxin A, a highly lethal phospholipase A2 from Vipera ammodytes ammodytes venomBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985